Abstract
Healing of peptic ulcers with drugs which do not in the least interfere with intragastric acidity has only been described for colloidal bismuth subcitrate (CBS). Healing rates both for duodenal and gastric ulcer are comparable with those obtained with H2-receptor antagonists (HRA). Relapse after CBS healing seems less and delayed compared to HRA-induced healing.